Quality of life and erectile dysfunction in patients with benign prostatic hyperplasia

Montiel-Jarquín, Álvaro José; Gutiérrez-Quiroz, Claudia T.; Pérez-Vázquez, Ana L.; Ortiz-Agustín, Johny J; García-Galicia, Arturo; Loría-Castellanos, Jorge

doi:10.24875/cirue.m20000246

Cited by 3 publications

(1 citation statement)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Only 17.6% of the participants considered it very poor or poor their quality of life, and the median score of the domains evaluated with the WHOQOOL-BREF questionnaire were over 70 with the exception of the Social relationships domain which include a question about satisfaction with the sexual life. These results are similar from those reported by Ezemenahi et al, in their study in hypertensive men with erectile dysfunction in southern Nigeria (31), but they differ slightly from what was reported by other authors in studies carried out in populations with other comorbidities, as well as in population studies, which can be explained by the differences in the population, the time of application of the survey and the questionnaire used (8, 11,32,33).…”

Section: Discussionsupporting

confidence: 89%

Mixed-design cross-sectional study on the impact of quality of life and self-esteem in Spanish men with erectile dysfunction during COVID-19 pandemic

Sandoval-Salinas,

Benitez,

Laborda

et al. 2024

Preprint

View full text Add to dashboard Cite

A cross-sectional study incorporating quantitative and qualitative analyses was conducted between 2020 and 2022, to evaluate the perception of quality of life and self-esteem in men with erectile dysfunction (ED), exploring factors associated with these psychological constructs. General and sexual-specific quality of life, self-esteem, and confidence, were measured in men with ED in Spain, using the World Health Organization Quality of Life-BREF (WHOQOL-BREF) questionnaire, Sexual Life Quality Questionnaire (SLQQ), and Self-Esteem and Relationship (SEAR) questionnaire. Comprehensive interviews were conducted to deepen the understanding of how ED impacts various aspects of life. 353 men participated in the quantitative phase and 21 in the qualitative phase. 54.9% of participants rated their general quality of life as good or very good. No association was found between the perceived quality of global life and the quality of erection or severity of ED. The median SLQQ score was 33.75 (IQR 22.5), and the median SEAR subscale self-esteem score was 37.5 (IQR 25). It was found that the duration of ED and the frequency of sexual activity influenced self-esteem and confidence in men with ED. In the qualitative assessment, the subjects considered that ED did not influence aspects of their life unrelated to sexual health.

show abstract

Section: Discussionsupporting

confidence: 89%

Mixed-design cross-sectional study on the impact of quality of life and self-esteem in Spanish men with erectile dysfunction during COVID-19 pandemic

Sandoval-Salinas,

Benitez,

Laborda

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

Prevalence and risk factors associated with erectile dysfunction in adults

Onchi,

García,

Hernández

2024

IJCAM

View full text Add to dashboard Cite

Introduction: Erectile dysfunction (ED) and associated risk factors represent a health problem that significantly affects the quality of life (QoL) of men worldwide, with individual, family, psychological and sexual involvement. Objective: To determine the prevalence of erectile dysfunction and associated risk factors in patients aged 30 to 65 years. Methods: Cross-sectional, descriptive study. To outpatients of HGZ/MF No.2, from December 2022 to May 2023, aged 30 to 65 years, who agree to participate in the study. Those under antidepressant treatment were excluded. Sociodemographic and clinical variables were analyzed. The IIEF-5 questionnaire was used to evaluate erectile dysfunction and the Montgomery-Asberg Scale for depression. Descriptive statistics and Chi2 were used to determine association between categorical variables with significant p-value <0.05 and SPSS v.23 for data analysis. Results: 206 participants were surveyed with mean age 46.42 ± 10.18 years, 62.62%(n=129) with arterial hypertension, 36.89%(n=76) with diabetes mellitus, 44.7%(n=92) with dyslipidemia and 38.40%(n=79) depression. 47.5%(n=98) presented some degree of erectile dysfunction, light 42.22%(n=87), mean 5.3%(n=11). We found association between ED with age [p<0.001], blood pressure stage [p<0.001], DM2 [p<0.001], smoking [p=0.001], BMI [p=0.002], physical activity [p<0.001] and depression [p<0.001]. Conclusions: Erectile dysfunction was present in half of the surveyed users, finding association with comorbidities; being important as first level physicians, the adequate metabolic control in them, promoting physical activity and a mental health for its prevention.

show abstract

The place of combined drugs based on regulatory peptides in the treatment of prostate diseases

Manasova,

Saverskaya,

Яковлев

et al. 2024

Androl. genit. hir.

View full text Add to dashboard Cite

Benign prostatic hyperplasia is the most common urological disease in men over 50 years of age. The decrease in the quality of life of patients with benign prostatic hyperplasia dictates the need to study the risk factors for the development of this disease, as well as to develop effective treatment strategies. The development of benign prostatic hyperplasia is characterized by proliferation of stromal and epithelial cells in the transitional zone of the organ that surrounds the urethra, which leads to compression of the urethra and the development of symptoms of the lower urinary tract. The drugs of first choice for the treatment of patients with prostatic hyperplasia are α1-adrenoblockers, among which the selective drug Tamsulosin is the most popular. According to the literature, the use of Tamsulosin is associated with the risk of developing a number of serious side effects, which can negatively affect the quality of life of patients and reduce their adherence to treatment. The article provides information about a combined drug containing bioregulatory peptides and tamsulosin in the form of suppositories, which helps to reduce the systemic effect of the drug and the development of undesirable side effects.

show abstract

Quality of life and erectile dysfunction in patients with benign prostatic hyperplasia

Cited by 3 publications

References 19 publications

Mixed-design cross-sectional study on the impact of quality of life and self-esteem in Spanish men with erectile dysfunction during COVID-19 pandemic

Mixed-design cross-sectional study on the impact of quality of life and self-esteem in Spanish men with erectile dysfunction during COVID-19 pandemic

Prevalence and risk factors associated with erectile dysfunction in adults

The place of combined drugs based on regulatory peptides in the treatment of prostate diseases

Contact Info

Product

Resources

About